Murali Ramachandra
CSO,
Microbiology
Biotech Umea
Sweden
Biography
Murali Ramachandra, Ph.D., CSO, Aurigene Discovery Technologies Limited Dr. Murali Ramachandra is the Chief Scientific Officer at Aurigene Discovery Technologies Limited, a biotech company engaged in drug discovery for cancer and inflammatory diseases. At Aurigene, Dr. Ramachandra has been mentoring and leading drug discovery efforts, which have resulted in successful delivery of multiple candidates, which are in different stages of clinical development. Dr. Ramachandra had earlier worked on various aspects of cancer and inflammation at Schering-Plough Pharmaceuticals and National Institutes of Health. He was previously a postdoctoral fellow at University of Kansas Medical Center and DuPont Experimental Station after receiving Ph.D. from University of Idaho. With an overall research experience of >25 years, he has coauthored more than 55 publications in peer-reviewed journals and is an inventor of twelve granted U.S. patents.
Research Interest
Microbiology
